Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Joslin Scientists Find That Salsalate… >
Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 Diabetes

Published: July 2, 2013.
By Joslin Diabetes Center
http://www.joslin.org

BOSTON – July 1, 2013 -- Joslin scientists report that salsalate, a drug used to treat arthritis, lowers blood glucose and improves glycemic control in type 2 diabetes. These findings, which were published today by the Annals of Internal Medicine, provide additional evidence that salsalate may be an effective drug to treat type 2 diabetes.

The scientists became interested in studying salsalate, an anti-inflammatory drug, after research conducted by Steven Shoelson, M.D., Ph.D., Head of the Section on Pathophysiology and Molecular Pharmacology and Professor of Medicine at Harvard Medical School, identified inflammation as a factor in the development of type 2 diabetes.

Stage 1 of TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) evaluated varying doses of salsalate in 108 participants with type 2 diabetes for 14 weeks. This study was reported in the Annals of Internal Medicine in 2010. The current findings are based on Stage 2 of TINSAL-T2D, which evaluated 286 participants with type 2 diabetes for 48 weeks. The subjects' blood glucose was inadequately controlled on current diabetes medications. Participants were randomized into salsalate and placebo groups.

After 48 weeks of treatment, the mean hemoglobin A1c level (a measurement of average blood glucose control over the past six to twelve weeks) was 37 percent lower in the salsalate group compared to the placebo group. The decrease in fasting glucose concentration was 15 mg/dl greater in the salsalate group than the placebo group. Patients in the salsalate group required fewer additional diabetes medications to control their blood sugar than patients in the placebo group.

"It's exciting that salsalate is effective in lowering blood sugar," says Allison Goldfine, M.D., lead author and Head of the Section of Clinical, Behavioral and Outcomes Research, and an Associate Professor of Medicine at Harvard Medical School. "Salsalate may have an important role in diabetes treatment and may also help us learn more about how inflammation contributes to the development of type 2 diabetes."

The salsalate group also showed improvements in markers associated with coronary risk: a 9 percent reduction in triglycerides and a 27 percent increase in adiponectin, a potentially cardioprotective protein from adipocytes. Uric acid, which is associated with cardiometabolic conditions and progression of renal disease, decreased 18 percent in the salsalate group. "The reductions in these cardiovascular risk factors paralleled improved glycemia," says Dr. Goldfine. However, the salsalate group also exhibited modest increases in LDL cholesterol and urine albumin, and had a slight increase in weight, which can indicate negative effects on heart or kidney function.

Salsalate's anti-inflammatory effects were evidenced by reductions in circulating white blood cells, neutrophils and lymphocytes, which are elevated in obesity and metabolic syndrome, but all remained within normal range.

The next step in determining whether salsalate is a safe drug for use as a diabetes medication and can receive FDA approval is to assess its effects on the progression of heart disease. Dr. Goldfine is currently leading a study, TINSAL-CVD, which is evaluating how salsalate affects coronary artery plaque volume in participants with established coronary artery disease. The results should be available in two years. "The study will help us better understand the risk/benefit ratio of using salsalate to treat diabetes," says Dr. Goldfine.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Heart 
7/1/13 
DNA Particles in the Blood May Help Speed Detection of Coronary Artery Disease
By American Heart Association
DALLAS, July 1, 2013 — DNA fragments in your blood may someday help doctors quickly learn if chest pain means you have narrowed heart arteries, according to a new …
Coronary 
3/14/10 
Family History Is Strong Predictor of Obstructive Coronary Artery Disease Using CCTA
By Henry Ford Health System
In the largest study of its kind to date using cardiac computed tomography angiography, people with a family history of early signs of coronary artery disease are at higher …
Disease 
7/13/12 
★★★ 
Noninvasive Imaging Technique May Help Kids with Heart Transplants
By Washington University School of Medicine
Cardiologists at Washington University School of Medicine in St. Louis have developed a noninvasive imaging technique that may help determine whether children who have had heart transplants are showing …
Disease 
6/16/14 
Gender-specific Research Improves Accuracy of Heart Disease Diagnosis in Women
By American Heart Association
Diagnosing coronary heart disease in women has become more accurate through gender-specific research that clarifies the role of both obstructive and non-obstructive coronary artery disease as contributors to ischemic …
Celiac 
3/31/14 
Celiac Disease Linked to Increased Risk of Coronary Artery Disease
By American College of Cardiology
People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American …
Technique 
10/11/11 
The Next Stage of Heart Function Testing
By Springer
A new non-invasive technique for measuring how well the heart and blood vessels function in patients already suffering from coronary artery disease could, in a single test, identify which …
Disease 
6/26/12 
EVINCI Results Could Lead to 75% Reduction of Invasive Procedures for Patients with Suspected CAD
By European Society of Cardiology
Madrid, 26 June 2012: Preliminary findings from the EVINCI study show that the prevalence of "significant" coronary artery disease in patients with chest pain symptoms is lower than expected …
Women 
3/7/13 
Rehab Associated with Reduced Risk of Death in Women with CAD
By American College of Cardiology
SAN FRANCISCO (March 7, 2013) —Women with coronary artery disease who completed a 12-week cardiac rehabilitation program were two-thirds less likely to die compared to those who were not …
Plaque 
8/16/11 
Fat Around Heart May Be Early Indicator of Coronary Disease
By Radiological Society of North America
OAK BROOK, Ill. – Researchers have found more evidence supporting the role of fat around the heart in promoting atherosclerosis, according to a study published online in the journal …
Diabetes 
5/7/13 
Type 1 Diabetes And Heart Disease Linked by Inflammatory Protein
By Columbia University Medical Center
NEW YORK, NY (May 7, 2013) — Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood …
Heart 
10/31/13 
Women Under 60 with Diabetes at Much Greater Risk for Heart Disease
By Johns Hopkins Medicine
Results of a Johns Hopkins study published today in the journal Diabetes Care found that young and middle-aged women with type 2 diabetes are at much greater risk of …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition